Evidence of aspirin benefit and risk

Evidence of aspirin benefit and risk

High quality data answers important questions   Principal Investigator to the Australian arm of the ASPREE trial, Professor John McNeil says health authorities require a high level of evidence about the balance of benefits and risks of aspirin in healthy people...
New ASPREE Milestones!

New ASPREE Milestones!

Together we’ve reached a number of very important recruitment milestones!   1) ASPREE participants in the USA and Australia = 16,500 2) ASPREE participants in Australia = 14,500 3) ASPREE participants in Victoria = 10,500 4) ASPREE participants in Tasmania =...
Month: May 2014